FBXO11 and myelodysplastic syndrome: Here, we provide evidence that ubiquitylation events mediated by FBXO11 (58, 59) could restructure RNA-binding protein networks in MDS HSPCs, potentially underlying the limited therapeutic window for targeting any one spliceosome component.